FDA Import Refusal SCS-7054617-8/10002/1 — Westin Resort & Spa
The FDA refused shipment SCS-7054617-8/10002/1 from Westin Resort & Spa (Canada) on May 27, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75
Refusal details
- Date
- May 27, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 75